Results 31 to 40 of about 3,530,670 (192)

Factors aggravating or precipitating acne in Indian adults: A hospital-based study of 110 cases

open access: yesIndian Journal of Dermatology, 2018
Background: Although acne is principally a disorder of adolescence, the number of adult patients with acne is increasing. Adult acne is defined as the presence of acne beyond the age of 25 years. There is relatively few data on the prevalence and studies
Rani Maria George, Rajiv Sridharan
doaj   +1 more source

Prescribing Patterns of Oral Antibiotics and Isotretinoin for Acne in a Colorado Hospital System: Retrospective Cohort Study

open access: yesJMIR Dermatology, 2023
BackgroundGuidelines established by the American Academy of Dermatology recommend oral antibiotics as first-line therapy for mild, moderate, and severe acne.
Madeline J Adelman   +8 more
doaj   +1 more source

FASCE, the benefit of spironolactone for treating acne in women: study protocol for a randomized double-blind trial

open access: yesTrials, 2020
Background Acne vulgaris has increased in women over the past 10 years; it currently affects 20–30% of women. The physiopathology of adult female acne is distinguished from that of teenagers essentially by two factors: hormonal and inflammatory.
Alexandra Poinas   +18 more
doaj   +1 more source

Correlation of Hormonal Profile and Lipid Levels with Female Adult Acne in a Tertiary Care Center of Nepal

open access: yesJournal of Nepal Health Research Council, 2018
Background: Acne beyond 25 years of age is frequently associated with hormonal derangement in women. Hormonal association provides the impetus for hormonal therapy as well as underpins the need for blood investigations in this population.
Smriti Shrestha
doaj   +1 more source

Adult female acne: assessment of age, clinical picture, skin care habits and quality of life (questionnaire). [PDF]

open access: yes, 2023
Aim of the study: to investigate the associations between age, acne clinical presentation, skin care habits and quality of life in adult women with acne.
Česnavičiūtė, Inga,
core  

Acne resolution rates: Results of a single-blind, randomized, controlled, parallel phase III trial with EE/CMA (Belara (R)) and EE/LNG (Microgynon (R)) [PDF]

open access: yes, 2001
Background and Objective: Acne in women can often be successfully treated by the intake of oral contraceptives containing gestagens with anti-androgenic properties.
Zahradnik, H. P.   +4 more
core   +1 more source

Integrated targeted serum metabolomic profile and its association with gender, age, disease severity, and pattern identification in acne.

open access: yesPLoS ONE, 2020
BACKGROUND:Westernized diet and nutritional metabolism are important in acne pathogenesis, especially in adult patients. However, clinical and basic data are lacking.
Min Hee Kim   +3 more
doaj   +1 more source

Identifying acne treatment uncertainties via a James Lind Alliance Priority Setting Partnership [PDF]

open access: yes, 2015
Objectives: The Acne Priority Setting Partnership (PSP) was set up to identify and rank treatment uncertainties by bringing together people with acne, and professionals providing care within and beyond the National Health Service (NHS). Setting: The
Whitehouse, H   +25 more
core   +1 more source

Impact of Parallel Topical Treatment with Nadifloxacin and Adapalene on Acne Vulgaris Severity and Quality of Life: A Prospective, Uncontrolled, Multicentric, Noninterventional Study

open access: yesBiomedicine Hub, 2021
Introduction: Daily parallel application of adapalene and nadifloxacin has been determined to be effective and well tolerated in patients with acne vulgaris in randomized, controlled clinical studies.
Claudia Neumeister   +3 more
doaj   +1 more source

Adult female acne: a new paradigm

open access: yes, 2013
In the adult female, acne is a chronic condition with a substantial negative psychological, social and emotional impact. Based on time of onset, two subtypes of adult female acne are recognized: 'persistent acne' is a continuation of the disease from ...
Yutskowskaya, Y   +17 more
core   +1 more source

Home - About - Disclaimer - Privacy